Remedium Lifecare Q1 Results Revenue Up 2.94% QoQ but Down 76.49% YoY

Remedium Lifecare Quarterly Growth Comparison

Remedium Lifecare Q1 Results: Remedium Lifecare's financial performance showed mixed results in the first quarter of June 2024. The company earned 77.70 crores in total revenue, which is slightly up from the previous quarter’s 75.58 crores but down by 76.49% compared to the same quarter last year. This large drop year-over-year indicates a significant decline in revenue over the past year.

Remedium Lifecare spending on general and administrative expenses was 0.22 crores, which is a decrease from the previous quarter but still slightly less than last year’s spending. Depreciation and amortization costs stayed the same as last quarter and last year, showing no significant change. However, other operating expenses, which were negative this quarter, dropped sharply compared to last quarter and were lower than last year’s figure.

Remedium Lifecare’s operating expenses decreased slightly from the previous quarter but were much lower compared to last year. This helped the company achieve an operating income of 2.27 crores, reversing a loss from the previous quarter, though still down by 68.82% compared to last year. Net income, or profit after all expenses, was 1.64 crores, an improvement from last quarter but also significantly lower compared to the same period last year. The diluted normalized earnings per share (EPS) dropped to 0.04, down from 0.52 last year, reflecting the lower profitability per share.

Here's a summary of Remedium Lifecare's Q1 results for June 2024:

Source: Here 

For More Q1 Results check our Twitter Page

Visit our website for more Q1 results

Remedium Lifecare Q1 Results 

The financial results for Remedium Lifecare for the quarter ending June 30, 2024, show how the company performed financially. For this quarter, the company earned ₹404.17 lakhs from its main business activities, and there was no additional income reported. This gives a total revenue of ₹404.17 lakhs. The company's expenses included ₹55.90 lakhs for the cost of materials and ₹7.27 lakhs for employee benefits. Other expenses were ₹5.61 lakhs for depreciation and ₹1.07 lakhs for various other costs. In total, expenses amounted to ₹73.20 lakhs.

Subtracting the total expenses from the total revenue, Remedium Lifecare made a profit of ₹226.63 lakhs before paying taxes. There were no current taxes or previous year’s tax adjustments, but deferred taxes resulted in a small adjustment of ₹1.93 lakhs. After accounting for these taxes, the final profit for the quarter was ₹226.63 lakhs. This is the total amount the company earned after all costs and taxes.

Remedium Lifecare’s earnings per share (EPS), which shows how much profit is attributed to each share of the company, was ₹0.06. This result indicates that the company had a positive quarter, making a decent profit while keeping expenses under control.

Here's a simplified breakdown of the financial results for the quarter ended June 30, 2024, as provided in the statement:

(₹ in Lakhs except for EPS)

Remedium Lifecare Stock Metrics

The table provides key financial information about Remedium Lifecare. The company has a market capitalization of ₹419 crore, which reflects its total value in the stock market. Its current stock price is ₹10.4, with a high of ₹42.4 and a low of ₹8.37 in the recent past. The Price-to-Earnings (P/E) ratio is 18.0, indicating how much investors are willing to pay for each unit of earnings. 

Here’s the information in table format:

Quarterly Results 

The table shows financial performance for Remedium Lifecare over three periods: December 2023, March 2024, and June 2024. In December 2023, the company had high sales of 1,834.18 crores and expenses of 1,779.48 crores, resulting in a profit of 68.78 crores and a profit margin of 2.98%.

Here’s the data for Dec 2023, Mar 2024, and Jun 2024:

About Remedium Lifecare 

Remedium Lifecare formerly known as Roxy Exports, is a company listed on the Bombay Stock Exchange (BSE). It specializes in trading active pharmaceutical ingredients (APIs) and their intermediates, such as Amino Isophthalic Acid, Tellurium(IV) Oxide, Grignard Reagent, Iodine, Selenium Metal Powder, and Trimethyl Sulfoxonium Iodide (TMSI). Remedium Lifecare has grown significantly in the pharmaceutical and healthcare sectors by focusing on high-quality products and adapting to market changes. 

Remedium Lifecare prides itself on its commitment to quality, aiming to deliver products with zero defects. They believe that "Quality is an ongoing process of building and sustaining relationships" and work hard to meet this goal through a well-trained team and advanced technology. Their supply chain management system is designed to ensure timely delivery, which has helped them build a strong customer base. 

Remedium Lifecare follows high ethical standards and is dedicated to providing valuable products to patients and societies worldwide. Their philosophy is guided by their chairman’s belief that success speaks louder than words, and they are focused on maintaining high standards in every aspect of their business.